Morgan Stanley Maintains Overweight on Exelon, Raises Price Target to $63
Morgan Stanley analyst Stephen Byrd maintains Exelon (NASDAQ:EXC) with a Overweight and raises the price target from $60 to $63.
Collaboration And Capitalism: Barron’s Wealth Gap Event Speakers Address American Financial Inequities
On Tuesday, Barron’s hosted The Wealth Gap: Ideas to Action, an event focused on the actions and initiatives corporate and philanthropic leaders are implementing to address the global wealth gap.
Morgan Stanley Maintains Overweight on Exelon, Raises Price Target to $60
Morgan Stanley analyst Stephen Byrd maintains Exelon (NASDAQ:EXC) with a Overweight and raises the price target from $58 to $60.
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 255 companies made new 52-week highs.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 258 companies set new 52-week highs.
Exelon Corporation Learned The Results Of The First PJM Capacity Auction Held Since 2018 For The 2022-2023 Planning Year; The Co.’s Byron, Dresden And Quad Cities Nuclear Plants Did Not Clear In The Auction
On June 2, 2021, Exelon Corporation (Exelon) learned the results of the first PJM capacity auction held since 2018 for the 2022-2023 planning year. Exelon Generation Company, LLC’s (Generation’s) Byron,
Morgan Stanley Maintains Overweight on Exelon, Lowers Price Target to $58
Morgan Stanley maintains Exelon (NASDAQ:EXC) with a Overweight and lowers the price target from $59 to $58.